Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study
Previous studies have investigated the occupancy of the serotonin reuptake transporter (SERT) after clinical doses of citalopram and other selective serotonin reuptake inhibitors. In the present study, the occupancies of SERT after multiple doses of escitalopram and citalopram were compared using th...
Saved in:
Published in | Psychopharmacologia Vol. 191; no. 2; pp. 333 - 339 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin
Springer
01.04.2007
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Previous studies have investigated the occupancy of the serotonin reuptake transporter (SERT) after clinical doses of citalopram and other selective serotonin reuptake inhibitors. In the present study, the occupancies of SERT after multiple doses of escitalopram and citalopram were compared using the radioligand [(123)I]ADAM and single photon emission computed tomography (SPECT).
Fifteen healthy subjects received escitalopram 10 mg/day (n = 6) or citalopram 20 mg/day (n = 9) for a total of 10 days. SERT occupancies in midbrain were determined with SPECT and [(123)I]ADAM at three different time points: at baseline (no medication) and at 6 and 54 h after last drug intake.
At 6 h after the last dose, mean SERT occupancies were 81.5 +/- 5.4% (mean+/-SD) for escitalopram and 64.0 +/- 12.7% for citalopram (p < 0.01). At 54 h after the last dose, mean SERT occupancies were 63.3 +/- 12.1% for escitalopram and 49.0 +/- 11.7% for citalopram (p < 0.05). The plasma concentrations of the S-enantiomer were of the same magnitude in both substances. For both drugs, the elimination rate of the S-enantiomer in plasma was markedly higher than the occupancy decline rate in the midbrain.
The significantly higher occupancy of SERT after multiple doses of escitalopram compared to citalopram indicates an increased inhibition of SERT by escitalopram. The results can also be explained by an attenuating effect of R-citalopram on the occupancy of S-citalopram at the SERT. |
---|---|
AbstractList | Previous studies have investigated the occupancy of the serotonin reuptake transporter (SERT) after clinical doses of citalopram and other selective serotonin reuptake inhibitors. In the present study, the occupancies of SERT after multiple doses of escitalopram and citalopram were compared using the radioligand [(123)I]ADAM and single photon emission computed tomography (SPECT).
Fifteen healthy subjects received escitalopram 10 mg/day (n = 6) or citalopram 20 mg/day (n = 9) for a total of 10 days. SERT occupancies in midbrain were determined with SPECT and [(123)I]ADAM at three different time points: at baseline (no medication) and at 6 and 54 h after last drug intake.
At 6 h after the last dose, mean SERT occupancies were 81.5 +/- 5.4% (mean+/-SD) for escitalopram and 64.0 +/- 12.7% for citalopram (p < 0.01). At 54 h after the last dose, mean SERT occupancies were 63.3 +/- 12.1% for escitalopram and 49.0 +/- 11.7% for citalopram (p < 0.05). The plasma concentrations of the S-enantiomer were of the same magnitude in both substances. For both drugs, the elimination rate of the S-enantiomer in plasma was markedly higher than the occupancy decline rate in the midbrain.
The significantly higher occupancy of SERT after multiple doses of escitalopram compared to citalopram indicates an increased inhibition of SERT by escitalopram. The results can also be explained by an attenuating effect of R-citalopram on the occupancy of S-citalopram at the SERT. Objectives: Previous studies have investigated the occupancy of the serotonin reuptake transporter (SERT) after clinical doses of citalopram and other selective serotonin reuptake inhibitors. In the present study, the occupancies of SERT after multiple doses of escitalopram and citalopram were compared using the radioligand [ super(123)I]ADAM and single photon emission computed tomography (SPECT). Methods: Fifteen healthy subjects received escitalopram 10 mg/day (n = 6) or citalopram 20 mg/day (n = 9) for a total of 10 days. SERT occupancies in midbrain were determined with SPECT and [ super(123)I]ADAM at three different time points: at baseline (no medication) and at 6 and 54 h after last drug intake. Results: At 6 h after the last dose, mean SERT occupancies were 81.5 plus or minus 5.4% (mean plus or minus SD) for escitalopram and 64.0 plus or minus 12.7% for citalopram (p < 0.01). At 54 h after the last dose, mean SERT occupancies were 63.3 plus or minus 12.1% for escitalopram and 49.0 plus or minus 11.7% for citalopram (p < 0.05). The plasma concentrations of the S-enantiomer were of the same magnitude in both substances. For both drugs, the elimination rate of the S-enantiomer in plasma was markedly higher than the occupancy decline rate in the midbrain. Conclusion: The significantly higher occupancy of SERT after multiple doses of escitalopram compared to citalopram indicates an increased inhibition of SERT by escitalopram. The results can also be explained by an attenuating effect of R-citalopram on the occupancy of S-citalopram at the SERT. Objectives: Previous studies have investigated the occupancy of the serotonin reuptake transporter (SERT) after clinical doses of citalopram and other selective serotonin reuptake inhibitors. In the present study, the occupancies of SERT after multiple doses of escitalopram and citalopram were compared using the radioligand [123I]ADAM and single photon emission computed tomography (SPECT). Methods: Fifteen healthy subjects received escitalopram 10 mg/day (n = 6) or citalopram 20 mg/day (n = 9) for a total of 10 days. SERT occupancies in midbrain were determined with SPECT and [123I]ADAM at three different time points: at baseline (no medication) and at 6 and 54 h after last drug intake. Results: At 6 h after the last dose, mean SERT occupancies were 81.5 +/- 5.4% (mean±SD) for escitalopram and 64.0 +/- 12.7% for citalopram (p 0.01). At 54 h after the last dose, mean SERT occupancies were 63.3 +/- 12.1% for escitalopram and 49.0 +/- 11.7% for citalopram (p < 0.05). The plasma concentrations of the S-enantiomer were of the same magnitude in both substances. For both drugs, the elimination rate of the S-enantiomer in plasma was markedly higher than the occupancy decline rate in the midbrain. Conclusion: The significantly higher occupancy of SERT after multiple doses of escitalopram compared to citalopram indicates an increased inhibition of SERT by escitalopram. The results can also be explained by an attenuating effect of R-citalopram on the occupancy of S-citalopram at the SERT. [PUBLICATION ABSTRACT] |
Author | Asenbaum, Susanne Spindelegger, Christoph Holik, Alexander Kasper, Siegfried Tauscher, Johannes Klein, Nikolas Attarbaschi, Trawat Lanzenberger, Rupert Sacher, Julia Geiss-Granadia, Thomas Mossaheb, Nilufar Dudczak, Robert |
Author_xml | – sequence: 1 givenname: Nikolas surname: Klein fullname: Klein, Nikolas – sequence: 2 givenname: Julia surname: Sacher fullname: Sacher, Julia – sequence: 3 givenname: Thomas surname: Geiss-Granadia fullname: Geiss-Granadia, Thomas – sequence: 4 givenname: Nilufar surname: Mossaheb fullname: Mossaheb, Nilufar – sequence: 5 givenname: Trawat surname: Attarbaschi fullname: Attarbaschi, Trawat – sequence: 6 givenname: Rupert surname: Lanzenberger fullname: Lanzenberger, Rupert – sequence: 7 givenname: Christoph surname: Spindelegger fullname: Spindelegger, Christoph – sequence: 8 givenname: Alexander surname: Holik fullname: Holik, Alexander – sequence: 9 givenname: Susanne surname: Asenbaum fullname: Asenbaum, Susanne – sequence: 10 givenname: Robert surname: Dudczak fullname: Dudczak, Robert – sequence: 11 givenname: Johannes surname: Tauscher fullname: Tauscher, Johannes – sequence: 12 givenname: Siegfried surname: Kasper fullname: Kasper, Siegfried |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18603179$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17235610$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU9rFDEYh4NU7Hb1A3iRINjb6JtkJjPrbVlbW6goWE8iIZs_mjKTjEnmMJ_BL22GXVnowVxe8vL8Qvg9F-jMB28QekngLQFo3yUASlgFwCvgnFfzE7QiNaMVhZaeoRUAYxUjTXeOLlJ6gHLqrn6GzklLWcMJrNCfG_fzl4k4mRhy8M7jHKVPY4i5bINS0yi9mrG0y32Y-uzG3mAdksFSD867VALZBY-DxSYpl2UfxigHrMIwymg0zgGf1u-x9Pg7oez2x_bD9hP--uVqd49TnvT8HD21sk_mxXGu0bfrq_vdTXX3-ePtbntXqZrSXPEajG67fUekBasbut9Y1VLNNdtsOJONrFtugHXAbKuV1ZawjpXJGmasJmyNLg_vjjH8nkzKYnBJmb6X3oQpCVJeqZtS5Bq9fgQ-hCn68jdBSbfhnPEFenWEpv1gtBijG2Scxb-OC_DmCMikZG9Lv8qlE9dxYKTdFI4cOBVDStHYEwJi8S0OvkXxLRbfYi6Z9lFmaXrRUay4_j_JvweYsE8 |
CODEN | PSYPAG |
CitedBy_id | crossref_primary_10_1038_bjp_2008_243 crossref_primary_10_1002_med_20245 crossref_primary_10_1007_s00213_016_4364_0 crossref_primary_10_1177_0269881115620462 crossref_primary_10_2174_1871527321666220301122807 crossref_primary_10_1016_j_neuroimage_2014_12_044 crossref_primary_10_1016_j_jpsychires_2008_11_004 crossref_primary_10_3389_fpsyt_2022_972141 crossref_primary_10_1590_S0100_879X2010005000007 crossref_primary_10_1016_j_nucmedbio_2010_02_010 crossref_primary_10_1097_YIC_0b013e32832a8ec8 crossref_primary_10_1586_14737175_8_4_537 crossref_primary_10_1097_FTD_0000000000001142 crossref_primary_10_1016_j_nucmedbio_2016_04_003 crossref_primary_10_1038_npp_2008_148 crossref_primary_10_2165_11204760_000000000_00000 crossref_primary_10_3390_biom10060880 crossref_primary_10_1016_j_euroneuro_2008_12_003 crossref_primary_10_1111_jsm_12980 crossref_primary_10_1017_S1461145709990149 crossref_primary_10_1016_j_neuroimage_2009_10_013 crossref_primary_10_1586_erd_09_64 crossref_primary_10_1038_s41380_021_01285_w crossref_primary_10_1177_0269881110374782 crossref_primary_10_1007_s00213_009_1649_6 crossref_primary_10_1016_S2215_0366_15_00232_1 crossref_primary_10_1177_0269881109349835 crossref_primary_10_1002_hbm_25760 crossref_primary_10_1097_FTD_0000000000000824 crossref_primary_10_1007_s00213_014_3595_1 crossref_primary_10_1016_j_pscychresns_2008_12_006 crossref_primary_10_1016_j_xphs_2017_05_007 crossref_primary_10_1016_j_pscychresns_2016_03_006 crossref_primary_10_1136_bmjopen_2011_000544 crossref_primary_10_1080_15622975_2021_1878427 crossref_primary_10_1016_j_euroneuro_2016_09_001 crossref_primary_10_2967_jnumed_107_046102 crossref_primary_10_1016_j_neuroimage_2012_07_023 crossref_primary_10_1097_JCP_0b013e3182228619 crossref_primary_10_1517_17425255_2014_863873 crossref_primary_10_1523_JNEUROSCI_2409_10_2010 crossref_primary_10_1016_j_euroneuro_2009_01_010 crossref_primary_10_1586_14737175_8_12_1853 crossref_primary_10_1007_s00259_010_1424_2 crossref_primary_10_1186_s13195_017_0298_y crossref_primary_10_3109_15563650903585937 crossref_primary_10_1016_j_neuroimage_2013_08_036 |
Cites_doi | 10.1007/s00213-006-0486-0 10.2165/00003495-200565160-00013 10.1097/00004850-200505000-00002 10.1016/S0028-3908(03)00138-2 10.1038/sj.mp.4001009 10.1016/j.nucmedbio.2004.10.001 10.1016/S0969-8051(00)00084-6 10.1016/S0149-2918(03)80076-0 10.1176/appi.ajp.158.11.1843 10.1097/00007691-199906000-00001 10.1185/030079905X65484 10.1111/j.1600-0447.1987.tb10566.x 10.1097/01.jcp.0000203201.34323.d3 10.1080/13651500410005504 10.1176/appi.ajp.161.5.826 10.2165/00023210-199708050-00009 10.1007/s00702-005-0429-7 10.1177/0091270005280860 10.1016/0006-8993(89)90511-8 10.3109/15622970209150599 10.1177/00912700122010041 |
ContentType | Journal Article |
Copyright | 2007 INIST-CNRS Springer-Verlag 2007 |
Copyright_xml | – notice: 2007 INIST-CNRS – notice: Springer-Verlag 2007 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U |
DOI | 10.1007/s00213-006-0666-y |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Chemoreception Abstracts Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Psychology Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Animal Behavior Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE Neurosciences Abstracts ProQuest One Psychology |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central Database Suite (ProQuest) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology Psychology |
EISSN | 1432-2072 |
EndPage | 339 |
ExternalDocumentID | 1228010111 17235610 18603179 10_1007_s00213_006_0666_y |
Genre | Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 40D 40E 95. 95~ AAYXX ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS CITATION RHV SBY SOJ ~EX -4W -BR .55 3SX IQODW KOW N2Q R9- X7M CGR CUY CVF ECM EIF NPM 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GNUQQ K9. M1P M2M NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U |
ID | FETCH-LOGICAL-c422t-640ed78b81af0fd52b9fc72d6d39963a5a476e03803f7dcfdf1383cfd353efd13 |
IEDL.DBID | 7X7 |
ISSN | 0033-3158 |
IngestDate | Fri Jul 11 03:40:52 EDT 2025 Thu Aug 14 10:37:03 EDT 2025 Sat Sep 28 07:57:53 EDT 2024 Tue Sep 20 22:57:10 EDT 2022 Tue Jul 01 04:16:30 EDT 2025 Thu Apr 24 23:02:38 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | [123I]ADAM Serotonin Escitalopram Psychotropic Reuptake inhibitor Photon SPECT Selective serotonin reuptake inhibitor Citalopram Multiple dose 5-HTT SERT Serotonin transporter Occupancy Neurotransmitter Antidepressant agent Emission tomography |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c422t-640ed78b81af0fd52b9fc72d6d39963a5a476e03803f7dcfdf1383cfd353efd13 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 17235610 |
PQID | 218966364 |
PQPubID | 47309 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_19634514 proquest_journals_218966364 pubmed_primary_17235610 pascalfrancis_primary_18603179 crossref_primary_10_1007_s00213_006_0666_y crossref_citationtrail_10_1007_s00213_006_0666_y |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007-04-01 |
PublicationDateYYYYMMDD | 2007-04-01 |
PublicationDate_xml | – month: 04 year: 2007 text: 2007-04-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Berlin |
PublicationPlace_xml | – name: Berlin – name: Germany – name: Heidelberg |
PublicationTitle | Psychopharmacologia |
PublicationTitleAlternate | Psychopharmacology (Berl) |
PublicationYear | 2007 |
Publisher | Springer Springer Nature B.V |
Publisher_xml | – name: Springer – name: Springer Nature B.V |
References | A Takano (666_CR22) 2006; 26 S Kasper (666_CR7) 2004; 8 O Lingjaerde (666_CR12) 1987; 334 JH Meyer (666_CR14) 2004; 161 A Mork (666_CR16) 2003; 45 SJ Kish (666_CR9) 2005; 32 N Herold (666_CR6) 2006; 113 666_CR20 JH Meyer (666_CR13) 2001; 158 S Noble (666_CR18) 1997; 8 MM Gutierrez (666_CR5) 2003; 25 N Moore (666_CR15) 2005; 20 M Bauer (666_CR2) 2002; 3 P Voirol (666_CR24) 1999; 21 N Klein (666_CR10) 2006; 3 L Colonna (666_CR4) 2005; 21 P Baumann (666_CR3) 1995; 6 D Murdoch (666_CR17) 2005; 65 S Oya (666_CR19) 2000; 27 I Backstrom (666_CR1) 1989; 486 C Sanchez (666_CR25) 2004; 174 B Sogaard (666_CR21) 2005; 45 J Tauscher (666_CR23) 2002; 7 F Larsen (666_CR11) 2001; 41 11920159 - Mol Psychiatry. 2002;7(3):317-21 16238906 - Curr Med Res Opin. 2005 Oct;21(10):1659-68 2525060 - Brain Res. 1989 May 8;486(2):261-8 12842122 - Neuropharmacology. 2003 Aug;45(2):167-73 11269575 - J Clin Pharmacol. 2001 Mar;41(3):340-6 16291715 - J Clin Pharmacol. 2005 Dec;45(12):1400-6 16266205 - Drugs. 2005;65(16):2379-404 15121647 - Am J Psychiatry. 2004 May;161(5):826-35 15812262 - Int Clin Psychopharmacol. 2005 May;20(3):131-7 11691690 - Am J Psychiatry. 2001 Nov;158(11):1843-9 16633150 - J Clin Psychopharmacol. 2006 Apr;26(2):188-91 12809966 - Clin Ther. 2003 Apr;25(4):1200-10 15721757 - Nucl Med Biol. 2005 Feb;32(2):123-8 15160261 - Psychopharmacology (Berl). 2004 Jul;174(2):163-76 10832081 - Nucl Med Biol. 2000 Apr;27(3):249-54 16465456 - J Neural Transm (Vienna). 2006 May;113(5):659-70 12479086 - World J Biol Psychiatry. 2002 Jan;3(1):5-43 16955282 - Psychopharmacology (Berl). 2006 Oct;188(3):263-72 24930684 - Int J Psychiatry Clin Pract. 2004;8 Suppl 1:15-8 10365634 - Ther Drug Monit. 1999 Jun;21(3):263-6 2887090 - Acta Psychiatr Scand Suppl. 1987;334:1-100 |
References_xml | – volume: 3 start-page: 263 year: 2006 ident: 666_CR10 publication-title: Psychopharmacology doi: 10.1007/s00213-006-0486-0 – volume: 65 start-page: 2379 year: 2005 ident: 666_CR17 publication-title: Drugs doi: 10.2165/00003495-200565160-00013 – volume: 20 start-page: 131 year: 2005 ident: 666_CR15 publication-title: Int Clin Psychopharmacol doi: 10.1097/00004850-200505000-00002 – volume: 45 start-page: 167 year: 2003 ident: 666_CR16 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(03)00138-2 – volume: 7 start-page: 317 year: 2002 ident: 666_CR23 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001009 – volume: 32 start-page: 123 issue: 2 year: 2005 ident: 666_CR9 publication-title: Nucl Med Biol doi: 10.1016/j.nucmedbio.2004.10.001 – volume: 27 start-page: 249 year: 2000 ident: 666_CR19 publication-title: Nucl Med Biol doi: 10.1016/S0969-8051(00)00084-6 – volume: 25 start-page: 1200 year: 2003 ident: 666_CR5 publication-title: Clin Ther doi: 10.1016/S0149-2918(03)80076-0 – volume: 174 start-page: 163 issue: 174 year: 2004 ident: 666_CR25 publication-title: Psychopharmacology – volume: 6 start-page: 287 year: 1995 ident: 666_CR3 publication-title: Rev Contemp Pharmacother – volume: 158 start-page: 1843 year: 2001 ident: 666_CR13 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.158.11.1843 – volume: 21 start-page: 263 year: 1999 ident: 666_CR24 publication-title: Ther Drug Monit doi: 10.1097/00007691-199906000-00001 – volume: 21 start-page: 1659 issue: 10 year: 2005 ident: 666_CR4 publication-title: Curr Med Res Opin doi: 10.1185/030079905X65484 – volume: 334 start-page: 1 year: 1987 ident: 666_CR12 publication-title: Acta Psychiatr Scand Suppl doi: 10.1111/j.1600-0447.1987.tb10566.x – volume: 26 start-page: 188 year: 2006 ident: 666_CR22 publication-title: J Clin Psychopharmacol doi: 10.1097/01.jcp.0000203201.34323.d3 – volume: 8 start-page: 15 year: 2004 ident: 666_CR7 publication-title: Int J Psychiatry Clin Pract doi: 10.1080/13651500410005504 – volume: 161 start-page: 826 year: 2004 ident: 666_CR14 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.161.5.826 – volume: 8 start-page: 410 year: 1997 ident: 666_CR18 publication-title: CNS Drugs doi: 10.2165/00023210-199708050-00009 – volume: 113 start-page: 659 year: 2006 ident: 666_CR6 publication-title: J Neural Transm doi: 10.1007/s00702-005-0429-7 – volume: 45 start-page: 1400 year: 2005 ident: 666_CR21 publication-title: J Clin Pharmacol doi: 10.1177/0091270005280860 – volume: 486 start-page: 261 year: 1989 ident: 666_CR1 publication-title: Brain Res doi: 10.1016/0006-8993(89)90511-8 – volume: 3 start-page: 5 year: 2002 ident: 666_CR2 publication-title: World J Biol Psychiatry doi: 10.3109/15622970209150599 – ident: 666_CR20 – volume: 41 start-page: 340 year: 2001 ident: 666_CR11 publication-title: J Clin Pharmacol doi: 10.1177/00912700122010041 – reference: 16955282 - Psychopharmacology (Berl). 2006 Oct;188(3):263-72 – reference: 24930684 - Int J Psychiatry Clin Pract. 2004;8 Suppl 1:15-8 – reference: 16238906 - Curr Med Res Opin. 2005 Oct;21(10):1659-68 – reference: 15121647 - Am J Psychiatry. 2004 May;161(5):826-35 – reference: 10832081 - Nucl Med Biol. 2000 Apr;27(3):249-54 – reference: 16633150 - J Clin Psychopharmacol. 2006 Apr;26(2):188-91 – reference: 11269575 - J Clin Pharmacol. 2001 Mar;41(3):340-6 – reference: 15721757 - Nucl Med Biol. 2005 Feb;32(2):123-8 – reference: 12809966 - Clin Ther. 2003 Apr;25(4):1200-10 – reference: 12842122 - Neuropharmacology. 2003 Aug;45(2):167-73 – reference: 15160261 - Psychopharmacology (Berl). 2004 Jul;174(2):163-76 – reference: 16465456 - J Neural Transm (Vienna). 2006 May;113(5):659-70 – reference: 16266205 - Drugs. 2005;65(16):2379-404 – reference: 11920159 - Mol Psychiatry. 2002;7(3):317-21 – reference: 2887090 - Acta Psychiatr Scand Suppl. 1987;334:1-100 – reference: 10365634 - Ther Drug Monit. 1999 Jun;21(3):263-6 – reference: 11691690 - Am J Psychiatry. 2001 Nov;158(11):1843-9 – reference: 2525060 - Brain Res. 1989 May 8;486(2):261-8 – reference: 15812262 - Int Clin Psychopharmacol. 2005 May;20(3):131-7 – reference: 12479086 - World J Biol Psychiatry. 2002 Jan;3(1):5-43 – reference: 16291715 - J Clin Pharmacol. 2005 Dec;45(12):1400-6 |
SSID | ssj0000484 ssj0068394 |
Score | 2.0862482 |
Snippet | Previous studies have investigated the occupancy of the serotonin reuptake transporter (SERT) after clinical doses of citalopram and other selective serotonin... Objectives: Previous studies have investigated the occupancy of the serotonin reuptake transporter (SERT) after clinical doses of citalopram and other... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 333 |
SubjectTerms | Adult Area Under Curve Biological and medical sciences Blood tests Brain Cerebellum Cinanserin - analogs & derivatives Citalopram - pharmacokinetics Citalopram - pharmacology Dose-Response Relationship, Drug Drug Administration Schedule Humans Inhibitor drugs Male Medical sciences Mesencephalon - drug effects Mesencephalon - metabolism Neurology Neuropharmacology Neurotransmitters Pharmacology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology Psychology. Psychoanalysis. Psychiatry Psychopharmacology Radiopharmaceuticals Serotonin Plasma Membrane Transport Proteins - drug effects Serotonin Plasma Membrane Transport Proteins - metabolism Serotonin Uptake Inhibitors - pharmacokinetics Serotonin Uptake Inhibitors - pharmacology Stereoisomerism Time Factors Tissue Distribution Tomography Tomography, Emission-Computed, Single-Photon |
Title | Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/17235610 https://www.proquest.com/docview/218966364 https://www.proquest.com/docview/19634514 |
Volume | 191 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwEB7BroRWQgjKKyyUOaA9oI1IY-dRLqhdWi1IrSroSpUQipzYPkFSmuwhv4E_zdh5qQf2FCWpc-iMZ76xx98H8I5SjNKhCtxAB5nLMx27saJ5JaZSpGHApWc1I1fr8PqGf90Fu7Y3p2zbKruYaAO1LDKzRv6BUhEhcxbyT_s_rhGNMpurrYLGfTg1zGXGqaNdNARibs5gNjchAYGGkZmZ82RB3O1wepZQ1DcaB6a2JjTv1kc56uFelPR36Ubn4v9A1Cak5WN41CJJnDWmfwL3VD6CB6t2r3wEF5uGlbq-xO1wyKq8xAvcDHzV9QjO-iBYP4W_TeMHkmcWlVmqxaqnPz9gYTmJKR6j1RbHrh0RZVEqFEdEvFhoVJRgzfLQ_iB-Y9fujlWBw-OPKHL8QZnty8_Z59kKv28WV1u0rLfP4Ga52F5du61gg5tx36_ckHtKRnEaT4T2tAz8dKqzyJehJBgUMhEIHoXKY7HHdCQzLfWECmS6soApLSfsOZzkRa5eAk610DGn8aZgo3dxkFJxyGSaal9l3HPA60yUZC2buRHV-JX0PMzWqont2yOrJrUD7_sh-4bK464fj4_sPoyIjS53NHXgvHOEpJ32ZdI7qQNv-7c0X80mjMhVcVsmJuJxQqkOvGi8Z_hy5DODZl_d-eVzOPNNyW_kkyav4aQ63Ko3hIuqdGy9fwyns-V8vqbrfLHefPsH380O4Q |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFD7UCloQ0fUWq-150D5Ig9lkJskKIksv7NpuWXALCyJxkpl5apN1kyL5Df4W_6NncmUf7FufQjKZeTlzbnPOfB_AO3IxSvuK21zzxGaJDu1QkV6JkRSxz5l0Ks7I2YU_uWRfl3y5BX_buzCmrbK1iZWhlllizsg_kiuiyNzz2ZfVL9uQRpniasugUe-KM1X-powt_zw9JvG-d93Tk8XRxG5IBeyEuW5h-8xRMgjjcCi0oyV345FOAlf6kly17wkuWOArxwsdTwcy0VIPKYmjp8c9peXQo3XvwX3yu47J9YJl0Bt-Zu581i8-BR41ArRn7q_xsK2oOhWAqWs4FUwuT9mDXW74xEcrkZN4dM2r8f_At3KAp0_gcRO54rjeak9hS6UDeDBravMDOJjXKNjlIS76S135IR7gvMfHLgew0xnd8hn8qRtNkDQhK8zRMBYd3PoaswoDmew_Vlzm2LY_osxyhWID-BczjYocujmOWq3FNbbt9Vhk2H_-hCLF7-RJpz_Gx-MZfpufHC2wQtl9Dpd3IssXsJ1mqXoFONJCh4zmmwSRxkIeUzLqyTjWrkqYY4HTiihKGvR0Q-JxFXW4z5VUo6pPkKQalRZ86KasauiQ237e25B7PyM0PODByILddiNEjZnJo04pLNjvRsk-mKKPSFV2k0fGwjKKii14We-efuXA9Uz0_PrWlffh4WQxO4_Opxdnu7BTH22bxqU3sF2sb9RbismKeK_SBISfd616_wCNikmi |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVKoqIQThZQrtHKAHVKuOvX4ECaHQJGooiSJIpUoVMmvv7gnsELtC_g38Iv4ds34qB3rryYqd3cvszDezO_t9AK8JYqTypGu6yo1NFqvADCT5FR8KHnkuE1apGTlfeOeX7NOVe7UDf5u7MLqtsomJZaAWaaz3yE8Jiigzdzx2ququiOV4-mH9y9QCUvqgtVHTqFbIhSx-U_WWvZ-NydRvbHs6WZ2dm7XAgBkz285Nj1lS-EEUDLiylHDtaKhi3xaeINj2HO5y5nvScgLLUb6IlVADKujo6biOVGLg0Lz3YNfXRVEPdj9OFssvHQwwfQO0-uFRGlLxQTv6NpsbNOerVklnamuFBV3ZUy1hFlsIeX_NMzKWqlQ2_p8Gl3A4fQgP6jwWR9XCewQ7MunD3rw-qe_D8bLixC5OcNVd8cpO8BiXHVt20Yf9NgQXj-FP1XaC5BdprjeKMW_J1zeYlozIhAZYKptj0wyJIs0k8i0aYEwVSoJ3vTm13vCf2DTbY55i9_od8gSvCVdn30bj0Ry_LidnKyw5d5_A5Z1Y8yn0kjSRzwGHiquA0XhdLtK3wI2oNHVEFClbxswywGpMFMY1l7qW9PgRtizQpVXDsmuQrBoWBrxth6wrIpHb_ny4ZfduRKBVwf2hAQfNQgjroJOFrYsYcNR-pWihj4B4ItObLNTxllGObMCzavV0M_u2o3PpF7fOfAR75Hbh59ni4gD2q31u3cX0Enr55ka-ogQtjw5rV0D4ftfe9w-B2k89 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Higher+serotonin+transporter+occupancy+after+multiple+dose+administration+of+escitalopram+compared+to+citalopram%3A+an+%5B123I%5DADAM+SPECT+study&rft.jtitle=Psychopharmacology&rft.au=Klein%2C+Nikolas&rft.au=Sacher%2C+Julia&rft.au=Geiss-Granadia%2C+Thomas&rft.au=Mossaheb%2C+Nilufar&rft.date=2007-04-01&rft.issn=0033-3158&rft.volume=191&rft.issue=2&rft.spage=333&rft_id=info:doi/10.1007%2Fs00213-006-0666-y&rft_id=info%3Apmid%2F17235610&rft.externalDocID=17235610 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |